First Light Diagnostics develops automated medical diagnostic systems for rapid and cost-effective diagnosis and treatment of life-threatening multidrug-resistant infections. Our $2.5 million ETF loan enabled the company to hire more full-time employees and expand its capabilities. First Light Diagnostics is developing its MultiPath™ technology platform, which can perform identification tests within 30 minutes, and antimicrobial susceptibility tests within four hours, directly from a patient sample without culture.
